| PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy? S Simon, N Labarriere Oncoimmunology 7 (1), e1364828, 2018 | 343 | 2018 |
| Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage A Fluckiger, R Daillère, M Sassi, BS Sixt, P Liu, F Loos, C Richard, ... Science 369 (6506), 936-942, 2020 | 269 | 2020 |
| De novo disruption of the proteasome regulatory subunit PSMD12 causes a syndromic neurodevelopmental disorder S Küry, T Besnard, F Ebstein, TN Khan, T Gambin, J Douglas, CA Bacino, ... The American Journal of Human Genetics 100 (2), 352-363, 2017 | 123 | 2017 |
| PD-1 expression conditions T cell avidity within an antigen-specific repertoire S Simon, V Vignard, L Florenceau, B Dreno, A Khammari, F Lang, ... Oncoimmunology 5 (1), e1104448, 2016 | 71 | 2016 |
| PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapy S Simon, V Voillet, V Vignard, Z Wu, C Dabrowski, N Jouand, T Beauvais, ... Journal for immunotherapy of cancer 8 (2), 2020 | 67 | 2020 |
| Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes L Marotte, S Simon, V Vignard, E Dupre, M Gantier, J Cruard, JB Alberge, ... Journal for Immunotherapy of Cancer 8 (1), 2020 | 30 | 2020 |
| Dual targeting with CAR T cells to limit antigen escape in multiple myeloma S Simon, SR Riddell Blood Cancer Discovery 1 (2), 130-133, 2020 | 24 | 2020 |
| Emergence of high-avidity Melan-A–Specific Clonotypes as a reflection of Anti–PD-1 clinical efficacy S Simon, V Vignard, E Varey, T Parrot, AC Knol, A Khammari, N Gervois, ... Cancer Research 77 (24), 7083-7093, 2017 | 21 | 2017 |
| Tumor-infiltrating lymphocytes make inroads in non–small-cell lung cancer JR Veatch, S Simon, SR Riddell Nature Medicine 27 (8), 1339-1341, 2021 | 19 | 2021 |
| PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy? OncoImmunology. 7: e1364828 S Simon, N Labarriere | 16 | 2017 |
| Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients B Dréno, A Khammari, A Fortun, V Vignard, S Saiagh, T Beauvais, ... Cancer Immunology, Immunotherapy 70 (10), 3015-3030, 2021 | 12 | 2021 |
| TCR analyses of two vast and shared melanoma antigen-specific T cell repertoires: common and specific features S Simon, Z Wu, J Cruard, V Vignard, A Fortun, A Khammari, B Dreno, ... Frontiers in Immunology 9, 1962, 2018 | 12 | 2018 |
| Anti-tumor efficacy of PD-L1 targeted alpha-particle therapy in a human melanoma xenograft model M Capitao, J Perrin, S Simon, S Gouard, N Chouin, F Bruchertseifer, ... Cancers 13 (6), 1256, 2021 | 10 | 2021 |
| Synthetic receptors for logic gated T cell recognition and function S Simon, G Bugos, AI Salter, SR Riddell Current opinion in immunology 74, 9-17, 2022 | 8 | 2022 |
| Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicity TB Shabaneh, AR Stevens, SM Stull, KR Shimp, BW Seaton, EA Gad, ... Journal for Immunotherapy of Cancer 12 (2), 2024 | 5 | 2024 |
| Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networks CA Jaeger-Ruckstuhl, Y Lo, E Fulton, OG Waltner, TB Shabaneh, S Simon, ... Immunity 57 (2), 287-302. e12, 2024 | 4 | 2024 |
| Impact of gamma-secretase inhibition on the multiple myeloma immune microenvironment D Coffey, O Landgren, AJ Cowan, PA Atilla, S Simon, M Pont, ... Blood 142, 4683, 2023 | 1 | 2023 |
| Synthetic HLA-independent T cell receptors for cancer immunotherapy S Simon, G Bugos, SR Riddell Cancer Cell 40 (4), 359-361, 2022 | 1 | 2022 |
| Effectiveness of Oral Nutritional Supplement Use on Nutritional Status of Community-Dwelling Elderly Receiving Home-Delivered Meals GJ Hill, MA Gorman, S Simon, L Frawley, K Whitten, L Wanner, M Parra, ... Journal of the Academy of Nutrition and Dietetics 112 (9), A96, 2012 | 1 | 2012 |
| Differential impact of genetic deletion of TIGIT or PD-1 on melanoma-specific T-lymphocytes G Cadiou, T Beauvais, L Marotte, S Lambot, C Deleine, C Vignes, ... OncoImmunology 13 (1), 2376782, 2024 | | 2024 |
Raphael GottardoLausanne University Hospital and University of Lausanne在 chuv.ch 的电子邮件经过验证
